Polymicrobial orbital apex syndrome in an immunocompromised patient: A multidisciplinary diagnostic challenge Authors: Elizabeth Y. X. Leong, Alex J. Y. Cheong, Jianbin Ding, Maryanne Romero Chew, Terese Huiying Low, Blanche X. H. Lim Published: 2026 ABSTRACT We report a diagnostically challenging case of polymicrobial orbital apex syndrome in an immunocompromised patient, emphasizing the importance of early multidisciplinary intervention and consideration of fungal aetiologies in high-risk individuals. A 70-year-old woman with multiple comorbidities presented with subacute left orbital pain and frontotemporal headache, with early signs of cranial nerve VI palsy. Despite initial stability, the patient deteriorated over 2 weeks, developing complete left ophthalmoplegia, proptosis, and vision loss. Further investigation demonstrated a polymicrobial skull base osteomyelitis with orbital apex and cavernous sinus involvement. Histopathology revealed necrotic material with chronic inflammation, and cultures identified Aspergillus flavus, Pseudomonas aeruginosa, Staphylococcus aureus, and Candida parapsilosis. The patient was treated with intravenous vancomycin, oral ciprofloxacin, and voriconazole for 6–8 weeks. Diagnosing orbital apex syndrome in immunocompromised individuals is complex and early imaging is critical. A high clinical suspicion for fungal infection should be maintained, with a strong role for timely tissue diagnosis. Coordinated multidisciplinary care and targeted antimicrobial therapy can prevent further morbidity from intracranial extension. Introduction Orbital apex syndrome (OAS) is a rare but potentially life-threatening condition characterized by dysfunction of cranial nerves II, III, IV, V1, and VI as they traverse the orbital apex. The aetiology of OAS is diverse, including neoplastic, inflammatory, infectious, and vascular causes. Fungal infections, particularly those caused by Aspergillus species, are increasingly recognized aetiologies especially in immunocompromised individuals.1 –3 Early diagnosis is crucial, but is often delayed due to non-specific presentations and challenges in tissue sampling.4 –6 This report describes a diagnostically and therapeutically complex case of polymicrobial OAS in a diabetic patient with multiple comorbidities, highlighting the need for multidisciplinary collaboration and a high index of suspicion for fungal disease in high-risk populations. Case report A 70-year-old Malay woman with a history of hypertension, hyperlipidaemia, type 2 diabetes mellitus, ischaemic heart disease, left above-knee amputation, and end-stage renal failure (ESRF) on haemodialysis presented with subacute onset of left eye pain and left frontotemporal headache. She had a known history of bilateral proliferative diabetic retinopathy treated with pan-retinal photocoagulation and prior intravitreal injection in the left eye. Visual acuity at baseline was 6/9 bilaterally. The patient was admitted to the vascular surgery service since August 2023 for complications following a left below-knee amputation, including recurrent wound infections and bacteraemia. In June 2024, she was referred for ophthalmologic evaluation due to new complaints of left eye pain and a left frontotemporal headache that had persisted for approximately 1 week. On initial examination at bedside, the right eye retained near-normal near visual acuity, while the left eye’s acuity was reduced to counting fingers at one meter. Pupillary examination revealed no relative afferent pupillary defect. Colour vision over the left eye was reduced. Anterior segment examination of the left eye revealed a nuclear sclerotic cataract, while fundoscopy showed quiescent diabetic retinopathy post retinal photocoagulation. Extraocular movements were full, and there was no evidence of proptosis or external lesions. Cranial nerves II, III, IV, and V were intact. In consideration of the patient’s ESRF, a non-contrasted MRI of the orbits and visual pathway (OAVP) was performed, which revealed soft tissue thickening at the left orbital apex extending to the superior orbital fissure and mild bulky appearance of the left anterior cavernous sinus (Figures 1 and 2). Mucosal thickening was seen in the bilateral ethmoid air cells, maxillary sinuses, and sphenoid sinuses, with heterogenous contents within the right maxillary sinus with wall sclerosis suggestive of inspissated mucus or fungal infection. Importantly, the optic nerve appeared structurally intact with no signs of compression. MRI OAVP sections showing contiguous soft tissue along left superior orbital fissure in superior aspect of orbital apex (left arrow) and mild bulky appearance of left anterior cavernous sinus (right arrow). OAVP: orbits and visual pathway. MRI OAVP showing slight increased T2 hyperintensity in extraocular muscle (left arrow) and mild oedema and fat straining in superior aspect of left orbit (right arrow). OAVP: orbits and visual pathway. Laboratory investigations, including inflammatory markers (erythrocyte sedimentation rate, C-reactive protein, and procalcitonin), autoimmune screening (anti-neutrophil cytoplasmic antibodies and immunoglobulin G subclass 4), infectious screening (tuberculosis and syphilis), and markers of granulomatous disease such as angiotensin-converting enzyme, were all unremarkable. A lumbar puncture was also performed to evaluate for central nervous system infection or other inflammatory or infiltrative causes of optic neuropathy, which was unremarkable. Based on the clinical and imaging findings, a preliminary diagnosis of left V1 neuropathic pain secondary to an orbital apex lesion was made. A multidisciplinary team discussion involving ophthalmology, neurology, otorhinolaryngology, and neurosurgery teams were held to determine the feasibility of a surgical biopsy. Given her high anaesthetic risk, the patient’s history of poor wound healing, and limited surgical yield due to the small size of the lesion, a decision was made for conservative management with close ophthalmic monitoring and a repeat MRI in 6 weeks. At this stage, the patient herself was not keen to proceed with surgical biopsy in view of the abovementioned risks. Her pain was well controlled with analgesia, and she remained clinically stable. However, 2 weeks later, the patient experienced clinical deterioration characterized by progressive cranial neuropathies involving cranial nerves VI, III, IV, II, and V1 sequentially. She developed a left complete ophthalmoplegia with proptosis and partial ptosis without anisocoria. Her left eye visual acuity dropped to no perception of light. A repeat MRI OAVP showed progression of the lesion with increased enhancement at the orbital apex and involvement of the anterior cavernous sinus (Figure 3). Repeat lumbar puncture remained unremarkable, and bedside nasal endoscopy was negative for necrotic or purulent tissue. Repeat MRI OAVP showing progression with ethmoidal sinus involvement (left arrow), orbital apex enhancement with dura thickening superiorly extending to anterior cavernous sinus (right arrow). OAVP: orbits and visual pathway. After a second multidisciplinary team review, the patient underwent endoscopic biopsy and sinus debridement. Intraoperative findings included new left posterior nasal septal necrosis, inflammation in the left posterior ethmoid and Onodi cells with bony dehiscence, bilateral sphenoid sinus concretions, right maxillary sinus fungal concretion, and pus in the right concha bullosa (Figure 4). Histopathology from sinonasal mucosa demonstrated necrotic debris and chronic inflammation without granuloma or malignancy. Intraoperative endoscopic biopsy and sinus debridement photos, showing left Onodi cell (left image) and left Onodi cell after stripping mucosa with area of dehiscence seen in bone (right image). Cultures from sinus (right maxillary and left sphenoid) tissues grew Pseudomonas aeruginosa, Staphylococcus aureus, and Candida parapsilosis. Fungal smear and polymerase chain reaction were positive for Aspergillus flavus. Acid-fast bacilli smear and tuberculosis polymerase chain reaction were negative. The infectious disease team was consulted, and the diagnosis was finalized as polymicrobial skull base osteomyelitis with orbital apex and cavernous sinus involvement, with causative organisms including Methicillin-resistant Staphylococcus aureus (MRSA), P. aeruginosa, C. parapsilosis, and A. flavus. She was initially started on intravenous vancomycin, oral ciprofloxacin, and oral voriconazole. In view of the patient’s renal impairment, dose adjustments were necessary. Target trough of intravenous vancomycin was 15–20 µg/mL while awaiting MRSA sensitivities – subsequent MRSA susceptibility testing showed sentivity to clindamycin; hence, vancomycin was switched to oral clindamycin 600 mg every 8 h 3 weeks after initiating treatment. Oral ciprofloxacin was started at 750 mg every 24 h for Pseudomonas coverage. Susceptibility testing for fungal species were not available in our institution; hence, oral voriconazole 200 mg twice daily was given empirically. During treatment, serum voriconazole levels were monitored. Weekly complete blood counts and liver function tests were performed, as well as regular electrocardiograms to identify any QTc prolongation. Serial MRIs performed 2 and 6 weeks after initiating therapy remained stable, with findings of persistent mucosal thickening and mucoid retention within the paranasal sinuses but no increased enhancement or involvement of the anterior cavernous sinus. The patient was continued on her regimen of oral ciprofloxacin, clindamycin, and voriconazole for 6 months total. During her course of treatment, there were no sigificant derangements of her biochemistry results and no adverse effects from antimicrobial therapy were noted. Inflammatory markers including her total white cell counts and erythrocyte sediment rate (ESR) were monitored regularly during treatment – total white cell count were stable within normal ranges, while ESR levels were stable but elevated possibly due to her end-stage renal disease. While visual outcomes remained poor due to late-stage optic neuropathy, systemic control of infection was achieved with no relapse of her infection. The patient defaulted her follow-up appointments following cessation of antimicrobial therapy. The timeline of events following the course of the patient’s progress has been included in Table 1. Table 1.Timeline of patient’s progress.DateSymptoms and clinical progressDiagnostic investigationsTherapeutic interventions10 June 2024Patient reported symptoms13 June 2024Initial MRI performed5 July 2024Clinical deterioration with worsening of symptoms and progression of ophthalmoplegiaRepeat MRI performed – progression of the lesion with increased enhancement at the orbital apex and involvement of the anterior cavernous sinus20 July 2024Cultures growing Pseudomonas aeruginosa, Staphylococcus aureus, and Candida parapsilosis, positive PCR for Aspergillus flavusBilateral endoscopic sinus surgery with biopsy of sinonasal tissue23 July 2024Patient started on intravenous vancomycin, oral ciprofloxacin, and oral voriconazole31 July 2024Serial MRI performed – stable findings12 August 2024Intravenous vancomycin switched to oral clindamycin5 September 2024Serial MRI performed – stable findingsSeptember–November 2024Gradual improvement in ocular motility23 January 2025Patient remained clinically stable with no relapse of infectionCombination antimicrobial therapy stopped. Patient defaulted further follow-up appointments Timeline of patient’s progress. Discussion OAS remains a rare and diagnostically challenging clinical entity. The involvement of the optic nerve and surrounding cranial nerves makes OAS a neuro-ophthalmic emergency requiring prompt recognition and management. In this case, the combination of systemic immunosuppression from diabetes and ESRF, prior hospitalization with recurrent infections, and subacute orbital pain with progressive cranial neuropathy raised clinical suspicion for an infective aetiology. Fungal causes of OAS, especially Aspergillus species, have been increasingly reported in tropical and subtropical regions.2,7,8 Invasive Aspergillus, particularly thermotolerant A. flavus, now accounts for an increasing share of OAS in hot, humid regions.9 –11 In immunocompromised patients, fungal invasion of the paranasal sinuses with subsequent extension to the orbit and skull base is a known pathway of spread. This case illustrates the importance of considering fungal infection in the differential diagnosis of orbital apex lesions, especially when initial workup is inconclusive. MRI findings, though non-specific, are helpful in identifying lesion location and guiding surgical planning.5,12 In our patient, gadolinium could not be given; so only non-contrast sequences were obtained. These showed a discrete orbital-apex mass that was mildly hypo- to isointense on T1-weighted imaging and slightly hyperintense on T2, outlining the lesion’s borders and its relationship to the optic nerve and cavernous sinus.13,14 When contrast is available, fungal abscesses typically display a thick, irregular peripheral rim that enhances intensely while the intracavitary projections remain non-enhancing; this rim often produces the classic “target sign” (hyperintense necrotic centre, hypointense middle ring, and hyperintense outer ring on T2) and is usually surrounded by pronounced vasogenic oedema.15,16 These characteristics help separate fungal abscesses from neoplasms, which tend to have smoother walls and lack the intracavitary hyphal projections seen on both contrast and non-contrast sequences. 13 However, imaging alone is insufficient to pinpoint the precise aetiology of an orbital apex lesion. Neoplastic and infective aetiologies aside, orbital apex lesions may also result from inflammatory processes or systemic-disease related inflammation of orbital structures. These may mimic the clinical and radiological features of neoplastic or infective diseases. 17 Histopathology can provide clues that narrow down the broad range of differentials especially if infective species are identified. However, when findings are non-diagnostic, proceeding with a biopsy of the lesion is recommended. 18 Tissue diagnosis remains the gold standard and should be pursued early when feasible, particularly in rapidly progressive cases.10,11 Planning for biopsy requires multidisciplinary input from ophthalmologists, radiologists, and surgeons to limit procedural risk while achieving sufficient yield. 18 In this patient, the delay in obtaining histopathological and microbiological confirmation was partly due to surgical risk concerns, which may have impacted the clinical course. Voriconazole has emerged as the antifungal agent of choice for invasive aspergillosis due to its favourable side effect profile, superior bone penetration, and improved survival compared to amphotericin B.19,20 In this case, combination antimicrobial therapy, including oral voriconazole, was necessary due to the polymicrobial nature of the infection. However, treating polymicrobial infections can be difficult due to the lack of validated protocols with limited clinical evidence for combination therapy. 21 This can be compounded by the absence of breakpoints for certain species such as rare Candida species and other yeasts. 22 Thus, treatment duration may vary depending on the patient’s immune status and the site and extent of infection. During treatment, patients should be monitored for improvement both clinically and via other metrics of disease activity such as infective biomarkers and imaging, as well as any adverse side effects of therapy. Learning points This case underscores the diagnostic challenges and severity of polymicrobial OAS in immunocompromised patients. In our patient, the inability to administer gadolinium contrast and concerns about surgical risk constrained early diagnostic options and delayed tissue confirmation, illustrating how practical limitations can impede timely management. Even so, a multidisciplinary approach – combining the best available imaging with judiciously timed tissue sampling – remains essential for establishing a diagnosis and initiating organism-directed therapy. Fungal OAS should be a key consideration in diabetic patients who present with orbital pain and progressive cranial neuropathies. When fungal infection is strongly suspected, the benefits of an earlier biopsy should be weighed carefully against operative risk. Despite the considerable morbidity and mortality associated with this condition, timely, targeted antimicrobial treatment can still achieve meaningful disease control and limit systemic spread.